Protagenic Therapeutics (PTIX) — Cash Flow Reinvestment Rate
Protagenic Therapeutics (PTIX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2010, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.72 Million. See Protagenic Therapeutics free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Protagenic Therapeutics Cash Flow Reinvestment Rate (1999–2008)
Historical reinvestment intensity for Protagenic Therapeutics across 7 annual periods. For the full cash flow conversion analysis, see PTIX operating cash flow.
Annual Cash Flow Reinvestment Rate for Protagenic Therapeutics (1999–2008)
Year-by-year capital reinvestment analysis for Protagenic Therapeutics. See Protagenic Therapeutics (PTIX) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2008 | 0.47x | $2.03 Million | $4.36 Million | $2.03 Million | ▲ +463.3% |
| 2006 | 0.08x | $77.00K | $931.00K | $77.00K | ▼ -89.5% |
| 2003 | 0.79x | $1.48 Million | $1.87 Million | $1.48 Million | ▲ +4.1% |
| 2002 | 0.76x | $1.78 Million | $2.35 Million | $1.78 Million | ▼ -69.8% |
| 2001 | 2.52x | $3.79 Million | $1.50 Million | $3.79 Million | ▲ +173.6% |
| 2000 | 0.92x | $3.23 Million | $3.51 Million | $3.23 Million | ▲ +276.3% |
| 1999 | 0.24x | $81.00K | $331.00K | $81.00K | — |